Log in to save to my catalogue

Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma

Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2293073594

Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

Adding three cycles of induction chemotherapy with gemcitabine and cisplatin to concurrent chemoradiotherapy improved 3-year recurrence-free survival (85.3%, vs. 76.5% with concurrent chemoradiotherapy alone) and overall survival (94.6% vs. 90.3%). Patients receiving induction chemotherapy were more likely to have grade 3 or 4 myelosuppression, nau...

Alternative Titles

Full title

Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2293073594

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2293073594

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1905287

How to access this item